Patients suffering from lung damage induced by cytokine storms caused by COVID-19 may be able to reduce their symptoms by using one of the non-psychoactive cannabinoids in cannabis, CBD, according to a new study that was published earlier this month. Scientists from the Dental College of Georgia (DCG) and the Medical College of Georgia who worked on the study, which was published in the Journal of Cellular and Molecular Medicine, that CBD has the ability to improve oxygen levels and reduce inflammation and physical lung damage that’s related to adult respiratory distress syndrome (ARDS).
The study demonstrates that CBD normalizes levels of a peptide named apelin, which is known to reduce inflammation. Apelin levels have proven to be low in patients who are infected with COVID-19.
If you’re in the market for high concentrations of legal CBD, check out the wide range of top shelf products from Swissx Oil and Confectionery based in Malibu, California.
Swissx has patented a an advanced technique for extracting cannabinoids from hemp seeds, yielding a CBD that is more pure and potent than other CBD extracts anywhere in the world. Swissx CBD oil is 57% pure CBD blended with organically grown essential oils.
One of Swissx’s latest products to help reduce lung damage is original blend 1000 MG Nano CBD oil, which is being sold in 1 gram syringes on the company’s official website. The CBD oil, which features an original blend of bee pollen and sweeteners from Switzerland, and is 100 percent natural and organic, is retailing for $50.
One noted medical expert who’s supporting the therapeutic modality of cannabis is Dr. Jennifer Ashton, who serves as ABC News’ Chief Medical Correspondent. While appearing on ‘Good Morning America’ on Thursday, October 22, Dr. Ashton noted that the studying of therapeutic modality of cannabis is still in its beginning stages, but based on the existing data, there is potential benefits to CBD in treating lung damage associated with COVID-19.
Like Dr. Ashton mentioned, the therapeutic modality of cannabis is still in its infancy, so the long-term beneficial effects of CBD on lung damage that’s caused by COVID-19 aren’t completely know yet. But Swissx’s 1000 MG Nano CBD oil is currently a leading choice to help patients who are suffering from lung damage that’s linked to the virus in the short-term.